文献速递消化道肿瘤与早癌消化内镜

意大利贲门失弛缓症患者食管鳞状细胞癌与腺癌风险:一项长期前瞻性队列研究

Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

该研究在1973至2018年间前瞻性随访566例原发性贲门失弛缓症患者,平均随访15.5年,评估食管鳞癌和腺癌风险。结果显示食管癌总体标准化发病比为104.2(95%CI 63.7-161),鳞癌为126.9(95%CI 71.0-209.3),腺癌为110.2(95%CI 35.8-257.2),年发病率仅0.24%。作者认为患者风险虽显著高于一般人群,但年发病率较低,对內镜监测有启示。

要点

  • 贲门失弛缓症患者食管鳞癌和腺癌风险均显著高于性别年龄匹配的一般人群。
  • 食管癌年发病率仅0.24%,鳞癌0.18%高于腺癌0.06%。
  • 男性超额风险高于女性,研究结果可能对內镜监测策略有启示。

核心结论

  • 贲门失弛缓症患者发生食管鳞状细胞癌和腺癌的风险均显著增加,但年发病率较低。

研究设计与样本

  • 1973年至2018年前瞻性队列研究,纳入566例原发性贲门失弛缓症患者,采用统一方案行上消化道內镜及食管活检随访。
  • 以标准化发病比(SIR)及95%置信区间(CI)比较患者与性别年龄匹配一般人群的食管癌相对风险。

主要发现

  • 566例患者中46%为男性,诊断时平均年龄48.1岁,自诊断起平均随访15.5年。
  • 共20例(15例男性)发生食管癌,其中15例鳞状细胞癌、5例腺癌。
  • 食管癌总体SIR为104.2(95%CI 63.7-161),鳞癌SIR为126.9(95%CI 71.0-209.3),腺癌SIR为110.2(95%CI 35.8-257.2)。
  • 男性超额风险高于女性。
  • 食管癌年发病率为0.24%,鳞癌为0.18%,腺癌为0.06%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Epidemiological studies assessing relative risk and incidence rate of esophageal cancer in patients with achalasia are scarce. We performed a long-term prospective cohort study to evaluate the risk of both squamous cell carcinoma and adenocarcinoma of the esophagus in these patients. METHODS: Between 1973 and 2018, patients with primary achalasia were followed by the same protocol including upper endoscopy with esophageal biopsies. Standardized incidence ratios (SIRs) with 95% confidence interval (CI) were used to estimate the relative risk of esophageal cancer in patients with achalasia compared with the sex- and age-matched general population. RESULTS: A cohort of 566 patients with achalasia (46% men, mean age at diagnosis: 48.1 years) was followed for a mean of 15.5 years since the diagnosis of achalasia. Overall, 20 patients (15 men) developed esophageal cancer: 15 squamous cell carcinoma and 5 adenocarcinoma. The risk of esophageal cancer was significantly greater than the general population (SIR 104.2, 95% CI 63.7-161), and this for both squamous cell carcinoma (SIR 126.9, 95% CI 71.0-209.3) and adenocarcinoma (SIR 110.2, 95% CI 35.8-257.2). The excess risk was higher in men than women. Annual incidence rate of esophageal cancer was only 0.24% and was higher for squamous cell carcinoma (0.18%) than adenocarcinoma (0.06%). DISCUSSION: Patients with achalasia have an excess risk of developing both squamous cell carcinoma and adenocarcinoma of the esophagus; however, this prospective cohort study confirms that the annual incidence of esophageal cancer is rather low. These findings may have implications for endoscopic surveillance of patients with achalasia.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Zagari RM, Marasco G, Tassi V, et al. Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy. Am J Gastroenterol. 2021. PMID: 33009050. doi:10.14309/ajg.0000000000000955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。